Navigation Links
Cardiovascular Diseases in India To be Studied Jointly By John Hopkins And Apollo Hospitals

Johns Hopkins Medicine International from the US and Apollo hospitals will undertake a combined study on the genetic reasons of cardiovascular disease in Indians.//

It was explained that in July last year, Apollo Hospitals had come into an agreement with Johns Hopkins to work jointly in areas like telemedicine, second opinion services, continuing medical education programmes, and participation in clinical trials.

Susan J. Zieman, assistant professor, medicines of John Hopkins on Tuesday in N.Delhi said, “The collaborative study will document the risk factors and identify genes that are associated with the premature CVD among Indians.” She further explained that the study is primarily being undertaken at the 3 Apollo hospitals, in Delhi, Hyderabad, and Chennai, to identify the risk factors in Asian Indians who have experienced myocardial infraction at a young age.

She further mentioning that “It will also investigate potential genetic variants associated with early onset of myocardial infraction, elevated risk factors and sub clinical CVD,” she said that the study will take samples from patients, their siblings and general people. Sunil Modi, a senior consultant and interventional cardiologist of the Apollo hospitals, while speaking to the media said, “Indians are 3.8 times more prone to the disease than residents of Singapore, three times more than Fijians, 2.4 times more than people of Trinidad, 1.4 times higher than South Africans and 1.5 times higher than British.”

Stating that almost around 8% of Indian population are probably suffering from heart diseases, Dr Modi said, “The study will take a sample of 1,500 people and conduct over 400 tests before reaching any conclusion. While the base of the study will be India, John Hopkins will provide us the some of the know how and research methodology. Of the over 400 tests some of the tests will also be conducted in the US. The clinical trails credibility of Johns Hopkins will definitely make our effort more meaningful.”

S.K. Aggarwal, a senior consultant in internal medicine said that the study would also look into the effect of administering ‘Polypill’ for reduction of CVD in patients. It was explained that Polypill is actually a mixture of three scheduled drugs, namely Aspirin, Statin, and ECE Inhibitor. It was explained that these three drugs are known for their action in reducing blood clot, cholesterol, and blood pressure.

Zieman said, “The polypill can be an effective medicine to reduce CVD but for that we will study the effect of the drug in its entirety. If successful the medicine can be used as a cost effective way to control the coronary heart diseases”


'"/>




Related medicine news :

1. High iron levels may cause Cardiovascular Disease in women
2. Air Pollution said To Increase Risk of Cardiovascular Disease
3. Link Between Alcohol Consumption And Cardiovascular Disease
4. Beer Found To Be Effective In Fighting Cardiovascular Disease
5. New Guidelines Found To Benefit Cardiovascular Treatment
6. Women With A High-Risk Of Cardiovascular Disease Under treated
7. Obesity and Physical inactivity is associated with Diabetes and Diabetes-Related Cardiovascular Comorbidities
8. Fitness levels in Men Correale with risk of Cardiovascular disease
9. Obesity Common Thread In Pregnancy Complications And Cardiovascular Woes
10. Olive Oil Found To Preserve Cardiovascular Health by Improving Function
11. Novel Rules And Regulations For Cardiovascular Catheterization Labs.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/22/2017)... NEV. (PRWEB) , ... August 22, 2017 , ... ... Academy of Anti-Aging Medicine recently spoke at a popular international aesthetics conference for ... has had on restoring his patients’ health and his growing practice. , ...
(Date:8/22/2017)... ... 22, 2017 , ... Nurses at Apple Rehab Watch Hill , a ... training and certification in Closed Pulse Irrigation™ (CPI) for wound care. This ... the Centers for Medicare and Medicaid Services, to have a CPI machine that will ...
(Date:8/22/2017)... ... 22, 2017 , ... “Without Love’s Beauty and Pleasures Life ... struggles faced while hoping for a better life. “Without Love’s Beauty and Pleasures ... who spent 13 years working with deprived/neglected adolescents and almost 20 years working ...
(Date:8/22/2017)... Park, KS (PRWEB) , ... August 22, 2017 , ... ... of products to fight Fatigue . , As the stress of modern life ... keep up the pace. Constant use of artificial stimulants can trap people in vicious ...
(Date:8/21/2017)... (PRWEB) , ... August 22, 2017 , ... ... but not without risk to health and safety. By learning and implementing best ... eliminated. , In this webinar, attendees will gain a better understanding of ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... 2017 Fenita J. Caldwell ... Pinnacle Lifetime Professional in the Field of Healthcare. ... Turing Pharmaceuticals, AG. Her skills and areas of ... ... of experience as a highly successful sales specialist ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
(Date:7/28/2017)... 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... ended June 30, 2017, and updated its financial outlook ... For the fiscal third quarter, Hill-Rom reported earnings ... diluted share in the prior-year period. These results reflect ... diluted share primarily related to the non-cash write-down of ...
Breaking Medicine Technology: